[HoKang Biotech] February 2026 Monthly Revenue: NT$0.48 Billion (YoY +20.9%)
NQ Score
67/100
N1 Content Completeness
7
AI Summary (NQ-processed)
HoKang Biotech (1783) announced its February 2026 revenue of NT$0.48 billion, achieving a year-on-year growth of 20.9%. The company, part of the biotechnology and medical industry, specializes in collagen and hyaluronic acid medical materials. This revenue increase reflects strong demand in the medical aesthetics and orthopedics markets.
AI analysis data is not yet available.